COVID-19 in Japan: insights from the first three months of the epidemic

Author:

Imai NatsukoORCID,Gaythorpe Katy AMORCID,Bhatia SangeetaORCID,Mangal Tara DORCID,Cuomo-Dannenburg GinaORCID,Unwin H Juliette TORCID,Jauneikaite ElitaORCID,Ferguson Neil MORCID

Abstract

AbstractBackgroundUnderstanding the characteristics and natural history of novel pathogens is crucial to inform successful control measures. Japan was one of the first affected countries in the COVID-19 pandemic reporting their first case on 14 January 2020. Interventions including airport screening, contact tracing, and cluster investigations were quickly implemented. Here we present insights from the first 3 months of the epidemic in Japan based on detailed case data.MethodsWe conducted descriptive analyses based on information systematically extracted from individual case reports from 13 January to 31 March 2020 including patient demographics, date of report and symptom onset, symptom progression, travel history, and contact type. We analysed symptom progression and estimated the time-varying reproduction number, Rt, correcting for epidemic growth using an established Bayesian framework. Key delays and the age-specific probability of transmission were estimated using data on exposures and transmission pairs.ResultsThe corrected fitted mean onset-to-reporting delay after the peak was 4 days (standard deviation: ±2 days). Early transmission was driven primarily by returning travellers with Rt peaking at 2.4 (95%CrI:1.6, 3.3) nationally. In the final week of the trusted period, Rt accounting for importations diverged from overall Rt at 1.1 (95% CrI: 1.0, 1.2) compared to 1.5 (95% CrI: 1.3, 1.6) respectively. Household (39.0%) and workplace (11.6%) exposures were the most frequently reported potential source of infection. The estimated probability of transmission was assortative by age. Across all age groups, cases most frequently onset with cough, fever, and fatigue. There were no reported cases of patients <20 years old developing pneumonia or severe respiratory symptoms.ConclusionsInformation collected in the early phases of an outbreak are important in characterising any novel pathogen. Timely recognition of key symptoms and high-risk settings for transmission can help to inform response strategies. The data analysed here were the result of robust and timely investigations and demonstrate the improvements to epidemic control as a result of such surveillance.

Publisher

Cold Spring Harbor Laboratory

Reference33 articles.

1. A cross-country core strategy comparison in China, Japan, Singapore and South Korea during the early COVID-19 pandemic

2. Ministry of Health Labour and Welfare Japan. Basic Policies for Novel Coronavirus Disease Control by the Government of Japan (Summary). 2020. https://www.mhlw.go.jp/content/10900000/000624436.pdf. Accessed 22 Oct 2021.

3. Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)

4. World Health Organization. Avoid the Three Cs. https://www.who.int/images/default-source/wpro/countries/malaysia/infographics/three-3cs/final-avoid-the-3-cs-poster.jpg. Accessed 20 Oct 2021.

5. Ministry of Health Labour and Welfare Japan. Situation report on COVID-19. https://www.mhlw.go.jp/stf/covid-19/kokunainohasseijoukyou_00006.html. Accessed 22 Oct 2021.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3